ArticleAnnals of hematology2023

Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect.

Salvatore Perrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.